aibioESMC ESCALON MEDICAL CORP
ESCALON MEDICAL CORP (ESMC) news
ESCALON MEDICAL CORP is a public biotech or pharmaceutical company listed on OTC under the ticker ESMC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest ESCALON MEDICAL CORP news
We have not published a story on ESCALON MEDICAL CORP yet. When there is news, it will appear here.
What ESCALON MEDICAL CORP does
Escalon Medical Corp. is a Pennsylvania corporation that develops, manufactures, markets and distributes medical devices for ophthalmic applications. Its products are sold through independent sales representatives, a network of distributors and internal sales employees to medical institutions throughout the world. Its A-Scan provides information about the internal structure of the eye and is primarily used to calculate lens power for implants. Its B-Scan is a diagnostic tool for eyes where the media are cloudy or opaque, and its UBM is a high frequency ultrasound device used for glaucoma evaluation and tumor evaluation. The company also makes pachymeters that measure corneal thickness, distributes Ispan intraocular gases used in detached retina surgery under a non-exclusive agreement with AirGas, Inc., and markets disposable surgical packs for vitreoretinal surgery. The company has received CE Mark on several of its products and must obtain FDA clearances or approvals before marketing in the United States. Its subsidiaries include Sonomed, Inc. and Escalon Digital Solutions, Inc.
| Product or program | What it is | Stage |
|---|---|---|
| A-Scan | Ultrasound device measuring eye structures and lens power for implants | sold through distributors and direct sales |
| B-Scan | Ultrasound imaging of the eye where media are cloudy or opaque | sold through distributors and direct sales |
| UBM | High frequency ultrasound for anterior segment of the eye | sold through distributors and direct sales |
| Ispan intraocular gases | C3F8 and SF6 gases used as temporary tamponade in retinal surgery | distributed under AirGas agreement |
| Surgical packs | Disposable surgical packs used in vitreoretinal surgery | marketed |
ESCALON MEDICAL CORP annual financials
| Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 |
|---|---|---|
| Research and development | $501,488 | $753,130 |
| Net income (loss) | $4.0 million | $105,525 |
| Cash from operations | -$402,604 | $380,725 |
| Cash and equivalents | $3.1 million | $545,835 |
Questions about ESCALON MEDICAL CORP
What is the ticker symbol of ESCALON MEDICAL CORP?
ESCALON MEDICAL CORP trades under the ticker ESMC on OTC.
Where is ESCALON MEDICAL CORP listed?
ESCALON MEDICAL CORP is listed on OTC.
Which country or territory is ESCALON MEDICAL CORP listed under?
Our directory records ESCALON MEDICAL CORP under United States.
Does aibio.space cover ESCALON MEDICAL CORP?
aibio.space lists ESCALON MEDICAL CORP among 2,820 public biotech companies and publishes its news here as stories appear.
What does ESCALON MEDICAL CORP develop?
Escalon Medical Corp. is a Pennsylvania corporation that develops, manufactures, markets and distributes medical devices for ophthalmic applications. Its products are sold through independent sales representatives, a network of distributors and internal sales employees to medical institutions throughout the world.
What is A-Scan from ESCALON MEDICAL CORP?
A-Scan: Ultrasound device measuring eye structures and lens power for implants Stage: sold through distributors and direct sales.
What is B-Scan from ESCALON MEDICAL CORP?
B-Scan: Ultrasound imaging of the eye where media are cloudy or opaque Stage: sold through distributors and direct sales.
Is ESCALON MEDICAL CORP profitable?
ESCALON MEDICAL CORP reported net income of $4.0 million for the fiscal year ended Jun 30, 2026, and used $402,604 of cash in operations, per its annual report to the SEC.
How much does ESCALON MEDICAL CORP spend on research and development?
$501,488 in the fiscal year ended Jun 30, 2026, per its annual report.
How much cash does ESCALON MEDICAL CORP have?
$3.1 million in cash at Jun 30, 2026, per its 10-K.
Investor discussion: ESCALON MEDICAL CORP
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-K. Source
Stock chart
Listing details
- Company
- ESCALON MEDICAL CORP
- Ticker
- ESMC
- Listing
- OTC
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction